发明名称 CYTOMEGALOVIRUS INHIBITOR COMPOUNDS
摘要 Compounds of Formula (I) wherein n, m, R1, R2, R3, R4, R5 and R6 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.;
申请公布号 US2015158861(A1) 申请公布日期 2015.06.11
申请号 US201314390243 申请日期 2013.04.03
申请人 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 发明人 Fader Lee;Lepage Olivier;Bailey Murray;Beaulieu Pierre Louis;Bilodeau Francois;Carson Rebekah J.;Giroux André;Godbout Cédrickx;Moreau Benoît;Naud Julie;Parisien Mathieu;Poirier Martin;Poirier Maude;Surprenant Simon;Thibeault Carl
分类号 C07D471/04;C07D519/00;A61K31/496;A61K31/5513;A61K31/506;C12N7/00;A61K31/4985;A61K31/5377;A61K31/541;A61K31/501;A61K45/06;A61K31/4375;A61K31/553 主分类号 C07D471/04
代理机构 代理人
主权项 1. A compound of Formula (I): wherein m is 1, 2 or 3; n is 1, 2 or 3; R1 is halo, —CN, (C1-6)alkyl, OH, —O—(C1-6)alkyl, (C1-6)haloalkyl or nitro; R2 is H or (C1-6)alkyl optionally substituted with halo, —CN, (C1-6)alkyl, (C1-6)haloalkyl, —(C3-7)cycloalkyl, —O—(C1-6)alkyl, OH, —NH2, —NH(C1-6)alkyl or —N((C1-6)alkyl)2; R3 is H, (C1-6)alkyl, (C3-7)cycloalkyl, aryl, heterocyclyl, heteroaryl, —(C1-6)alkyl-(C3-7)cycloalkyl, —(C1-6)alkyl-aryl, —(C1-6)alkyl-heterocyclyl or —(C1-6)alkyl-heteroaryl, wherein each said alkyl, cycloalkyl, aryl, heterocyclyl and heteroaryl, either alone or in combination with another radical, is optionally mono-, di-, or tri-substituted with R32; or R2 and R3, together with the N to which they are attached, are linked to form a heterocyclyl or heteroaryl; wherein each said heterocyclyl and heteroaryl are optionally mono-, di-, or tri-substituted with R32; R32 is each independently selected from the group consisting of R33, halo, oxo, —CN, OH, SH, —COOH, —O—(C1-6)alkyl, —S—(C1-6)alkyl, (C3-7)cycloalkyl, (C1-6)haloalkyl, —C(═O)—(C1-6)alkyl, —C(═O)—O—(C1-6)alkyl, —SO2NH2, —SO2—NH(C1-6)alkyl, —SO2—N((C1-6)alkyl)2, —SO(C1-6)alkyl, —SO2(C1-6)alkyl, —C(═O)—NH2, —C(═O)—NH(C1-6)alkyl, —C(═O)—N((C1-6)alkyl)2, —C(═O)—NH—SO2(C1-6)alkyl, —SO2—NH—C(═O)—(C1-6)alkyl, —NH2, —NH(C1-6)alkyl, —N((C1-6)alkyl)2, —NH(C3-7)cycloalkyl, —N((C1-6)alkyl)(C3-7)cycloalkyl, —NH—C(═O)(C1-6)alkyl, —NH—C(═O)—O(C1-6)alkyl, heterocyclyl (optionally substituted with (C1-6)alkyl) and heteroaryl (optionally substituted with (C1-6)alkyl); R33 is (C1-6)alkyl optionally mono- or di-substituted with OH, —O—(C1-6)alkyl, —NH2, —NH(C1-6)alkyl or —N((C1-6)alkyl)2; R4, R5 and R6 are each independently selected from the group consisting of halo, —CN, nitro, R42, —C(═O)—R42, —C(═O)OR42, —OR42, —SR42, —SOR42, —SO2R42, —N(R43)R42, —(C1-6)alkyl-N(R43)R42, —C(═O)—N(R43)R42, —N(R43)—C(═O)R42, —N(R43)—C(═O)—OR42, —O—C(═O)—N(R43)R42, —C(═O)—N(H)—SO2R42, —SO2—N(H)—C(═O)R42, —N(R43)—SO2R42 and —SO2—N(R43)R42; R42 is each independently selected from the group consisting of H, (C1-6)alkyl, (C2-6)alkenyl, (C2-6)alkynyl, —(C1-6)alkyl-(C3-7)cycloalkyl, —(C1-6)alkyl-aryl, —(C1-6)alkyl-heterocyclyl, —(C1-6)alkyl-heteroaryl, (C3-7)cycloalkyl, aryl, heterocyclyl and heteroaryl, wherein each said alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl and heteroaryl, either alone or in combination with another radical, is optionally substituted with 1 to 3 substituents each independently selected from the group consisting of: oxo, halo, —CN, OH, —COOH, —O—(C1-6)alkyl, —S—(C1-6)alkyl, (C3-7)cycloalkyl, —O—(C3-7)cycloalkyl, (C1-6)haloalkyl, —C(═O)—O—(C1-6)alkyl, —SO2NH2, —SO2—NH(C1-6)alkyl, —SO2—N((C1-6)alkyl)2, —SO(C1-6)alkyl, —SO2(C1-6)alkyl, —C(═O)—NH2, —C(═O)—NH(C1-6)alkyl, —C(═O)—N((C1-6)alkyl)2, —NH2, —NH(C1-6)alkyl, —N((C1-6)alkyl)2, —NH—C(═O)(C1-6)alkyl, —NH—C(═O)—O(C1-6)alkyl, —C(═O)—N(H)—SO2(C1-6)alkyl, —SO2—N(H)—C(═O)(C1-6)alkyl, and (C1-6)alkyl optionally mono- or di-substituted with OH, —O—(C1-6)alkyl, —S—(C1-6)alkyl, —SO(C1-6)alkyl, —SO2(C1-6)alkyl, —NH2, —NH(C1-6)alkyl, —N((C1-6)alkyl)2, —C(═O)-heterocyclyl, —C(═O)-heteroaryl, aryl, heterocyclyl or heteroaryl; R43 is H, (C1-6)haloalkyl or (C1-6)alkyl optionally mono- or di-substituted with OH, —O—(C1-6)alkyl, or —O—(C3-7)cycloalkyl; or a salt thereof.
地址 Ingelheim am Rhein DE